Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Advances in antimicrobial therapy].

W J Rodríguez1

  • 1Childrens Hospital, Washington, D.C. 20010.

Anales Espanoles De Pediatria
|June 1, 1992
PubMed
Summary

New antimicrobial agents, including beta-lactamase inhibitors, third-generation cephalosporins, carbapenems, quinolones, and macrolides, represent significant advancements in combating microbial infections.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spectroscopic and lasing properties of Ho:Tm:LuAG.

Optics letters·2009
Same author

Optochin resistance in Streptococcus pneumoniae: mechanism, significance, and clinical implications.

The Journal of infectious diseases·2001
Same author

Soft tissue and cartilage infection by Salmonella oranienburg in a healthy girl.

Southern medical journal·2001
Same author

The pediatric forum. Physician use of a telephone access line for infectious disease consultation.

Archives of pediatrics & adolescent medicine·2000
Same author

Streptococcus pneumoniae causes otitis media with higher fever and more redness of tympanic membranes than Haemophilus influenzae or Moraxella catarrhalis.

The Pediatric infectious disease journal·1999
Same author

Prospective, randomized, investigator-blinded study of the efficacy and safety of meropenem vs. cefotaxime therapy in bacterial meningitis in children. Meropenem Meningitis Study Group.

The Pediatric infectious disease journal·1999

Area of Science:

  • Microbiology and Infectious Diseases
  • Pharmacology and Drug Development

Context:

  • The rise of antimicrobial resistance necessitates the development of novel therapeutic agents.
  • Existing antimicrobial classes face challenges due to evolving resistance mechanisms.

Purpose:

  • To review recent advancements in antimicrobial drug development.
  • To highlight key emerging antimicrobial classes and their mechanisms.

Summary:

  • Discussion of new beta-lactamase inhibitors, crucial for overcoming resistance in beta-lactam antibiotics.
  • Overview of third-generation cephalosporins, carbapenems, and quinolones as potent antibacterial agents.
  • Exploration of novel macrolide antibiotics with improved efficacy and spectrum of activity.

Impact:

  • These developments offer new strategies to manage challenging bacterial infections.
  • Advancements in antimicrobials are vital for public health and infection control.
  • Potential to improve treatment outcomes for patients with resistant microbial pathogens.

Related Experiment Videos